Literature DB >> 1560544

Theiler's virus replication in brain macrophages cultured in vitro.

M Levy1, C Aubert, M Brahic.   

Abstract

Infection of the mouse with Theiler's virus is one of the best animal models for the study of multiple sclerosis, a chronic demyelinating disease of the human central nervous system. The identification of the virus target cell(s) is fundamental to an understanding of the viral persistence as well as the inflammation and demyelination observed in the chronic phase of the disease. This paper reports that a small fraction of brain macrophages grown in vitro can be efficiently infected with Theiler's virus without significant cytolytic effect. Viral replication as well as continuous production of infectivity were observed in these cultures.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560544      PMCID: PMC241085     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Simultaneous in situ detection of two mRNAs in the same cell using riboprobes labeled with biotin and 35S.

Authors:  S Ozden; C Aubert; D Gonzalez-Dunia; M Brahic
Journal:  J Histochem Cytochem       Date:  1990-07       Impact factor: 2.479

2.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

3.  Multiple sclerosis. Animal model:Theiler's virus infection in mice.

Authors:  M C Dal Canto; H L Lipton
Journal:  Am J Pathol       Date:  1977-08       Impact factor: 4.307

Review 4.  Macrophages and microglia in the nervous system.

Authors:  V H Perry; S Gordon
Journal:  Trends Neurosci       Date:  1988-06       Impact factor: 13.837

5.  Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection.

Authors:  H L Lipton; J Kratochvil; P Sethi; M C Dal Canto
Journal:  Neurology       Date:  1984-08       Impact factor: 9.910

6.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

Authors:  J M Austyn; S Gordon
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

7.  Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis.

Authors:  N Tsukada; K Miyagi; M Matsuda; N Yanagisawa; K Yone
Journal:  J Neurol Sci       Date:  1991-08       Impact factor: 3.181

8.  Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination.

Authors:  W Cammer; B R Bloom; W T Norton; S Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

9.  Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis.

Authors:  M Rodriguez; J L Leibowitz; P W Lampert
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

10.  A molecular analysis of mouse development from 8 to 10 days post coitum detects changes only in embryonic globin expression.

Authors:  D G Wilkinson; J A Bailes; J E Champion; A P McMahon
Journal:  Development       Date:  1987-04       Impact factor: 6.868

View more
  23 in total

1.  Theiler's virus infection of primary cultures of bone marrow-derived monocytes/macrophages.

Authors:  Cécile Martinat; Ignacio Mena; Michel Brahic
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Absence of perforin expression confers axonal protection despite demyelination.

Authors:  Charles L Howe; Jaimie D Adelson; Moses Rodriguez
Journal:  Neurobiol Dis       Date:  2006-11-16       Impact factor: 5.996

3.  Anti-CCL2 treatment inhibits Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  William J Karpus; Kevin J Kennedy; Brian T Fife; Jamie L Bennett; Mauro C Dal Canto; Steven L Kunkel; Nicholas W Lukacs
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 2.643

4.  The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system.

Authors:  M K Njenga; K Asakura; S F Hunter; P Wettstein; L R Pease; M Rodriguez
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Theiler's virus infection of perforin-deficient mice.

Authors:  C P Rossi; A McAllister; M Tanguy; D Kägi; M Brahic
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line.

Authors:  H Takata; M Obuchi; J Yamamoto; T Odagiri; R P Roos; H Iizuka; Y Ohara
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

7.  Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus.

Authors:  J K Olson; A M Girvin; S D Miller
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Inducible nitric oxide synthase in Theiler's murine encephalomyelitis virus infection.

Authors:  E L Oleszak; C D Katsetos; J Kuzmak; A Varadhachary
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

9.  Human HLA-DR transgenes protect mice from fatal virus-induced encephalomyelitis and chronic demyelination.

Authors:  Moses Rodriguez; Laurie Zoecklein; Jason G Kerkvliet; Kevin D Pavelko; Louisa Papke; Charles L Howe; Larry R Pease; Chella David
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

10.  Mutational analysis of the J-K stem-loop region of the encephalomyocarditis virus IRES.

Authors:  M A Hoffman; A C Palmenberg
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.